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Abstract
Background Reactive electroencephalography (EEG) back-
ground during therapeutic hypothermia (TH) is related to
favorable prognosis after cardiac arrest (CA), but its predictive
value is not 100 %. The aim of this study was to investigate
outcome predictors after a first reactive EEG recorded during
TH after CA.
Methods We studied a cohort of consecutive comatose adults
admitted between February 2008 and November 2012, after
successful resuscitation from CA, selecting patients with reac-
tive EEG during TH. Outcome was assessed at three months,
and categorized as survivors and non-survivors (no patient was
in vegetative state). Demographics, clinical variables, EEG
features, serum neuron-specific enolase (NSE) and procalcito-
nin, were compared using uni- and multivariable analyses.
Results A total of 290 patients were treated with TH after
cardiac arrest; 146 had an EEG during TH, which proved
reactive in 90 of them; 77 (86 %) survived and 13 (14 %)
died (without recovery from coma). The group of non-
survivors had a higher occurrence of discontinuous EEG
(p = 0.006; multivariate analysis p = 0.026), and a higher
serum NSE peak (p = 0.021; multivariate analysis
p = 0.014); conversely, demographics, and other clinical
variables including serum procalcitonin did not differ.
Conclusions A discontinuous EEG and high serum NSE
are associated with mortality after CA in patients with poor
outcome despite a reactive hypothermic EEG. This sug-
gests more severe cerebral damage, but not to higher extent
of systemic disease.
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Introduction
Hypoxic ischemic encephalopathy following cardiac arrest
(CA) represents a leading cause of mortality [1]. The
introduction of therapeutic hypothermia (TH) in the last
decade has contributed to the improvement of survival and
functional outcome [2–5], leading to increased attention on
issues related to prognostication. According to current
knowledge, lack of brainstem reflexes [6, 7], high serum
neuron-specific enolase (NSE) [8, 9], and non-reactive or
discontinuous electroencephalography (EEG) background
activity [6, 10] are considered to be relatively robust pre-
dictors of poor outcome after CA and TH. Moreover, we
recently found that the EEG background reactivity during
TH represents a reliable outcome predictor in this setting;
furthermore, hypothermic EEG features seem to correlate
with the extent of neurological damage [11]. In that study,
while the predictive value for mortality in patients without
EEG reactivity during TH was very high (23/23, 100 %),
4/38 (11 %) subjects died despite a reactive EEG.
We undertook the present analysis to identify clinical
variables correlating with poor outcome despite a reactive
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hypothermic EEG. The main objective was to assess if non-
survivors with a reactive EEG had a higher extent of
cerebral damage (i.e., higher NSE, other malignant EEG
signs) and/or a greater severity of systemic injury (i.e.,
higher procalcitonin (PCT)) [12, 13].
Methods
Patients and Procedures
We included all patients with a reactive EEG during TH
from our prospective registry of consecutive comatose
adults admitted between February 2008 and November
2012 to the Department of Intensive Care Medicine, after
successful resuscitation from CA and treated with TH,
according to our protocol (in line with current recom-
mendations [6]). Briefly, all patients received mild TH to
33 C for 24 h, using ice packs and IV ice-cold fluids,
together with a surface cooling device (Arctic Sun System,
Medivance, Louisville, CO). In a standardized approach,
midazolam (0.1 mg/kg/h) and fentanyl (1.5 lg/kg/h) were
given for sedation-analgesia, and vecuronium (0.1 mg/kg
boluses) to control shivering. Serum NSE was sampled at
24 and 48 h after CA, and analyzed with an automated
immunofluorescent assay (Thermo Scientific Brahms NSE
Kryptor Immunoassay); for the present study, the peak
level was recorded. Serum PCT was sampled at 24 h after
CA, during TH, using the ELFA method (Vidas Brahms
PCT assay, bioMerieux Inc., Geneva, Switzerland) [13],
with a detection limit of 0.05 lg/ml and an inter-plate
variance of under 20 % (normal values in our laboratory:
<0.25 lg/ml for detection of bacterial infections).
Decisions upon withdrawal of care were based on
multidisciplinary decisions according to our local protocol
[6]: occurrence of two or more of four criteria (1. unre-
active EEG background in normothermia, 2. treatment-
resistant myoclonus, 3. bilateral absence of N20 in
somatosensory evoked potentials in normothermia, and 4.
incomplete return of brainstem reflexes) after more than
48–72 h after CA, in normothermia and off sedation lead to
consideration of interruption of supportive care. Impor-
tantly, the EEG during hypothermia and NSE values were
not taken into consideration for the withdrawal of care.
Outcome at 3 months was assessed with a semistructured
interview using the Cerebral Performance Categories
(CPC): CPC 1 indicates full recovery; CPC 2 indicates
moderate disability (able to work at least part-time, and
independent for activities of daily living, with or without
neurological manifestations such as hemiplegia, seizures,
ataxia, dysarthria, dysphasia, or permanent memory or
mental changes); CPC 3 indicates severe disability (con-
scious, but fully dependent for daily support because of
severely impaired cognitive function). Patients with CPC 4
are comatose or in a persistent vegetative state, and those
with CPC 5 have died [12]. These variables were collected
prospectively according to the Utstein style [14].
EEG
Video-EEGs were performed per protocol during TH and
early after TH (during normothermia), with mostly 21
electrodes according to the international 10–20 system, for
20–30 min [6, 11]. The hypothermic EEG was performed
at least 6 h after CA, at a temperature of 33–34 C (in all
patients). Normothermic EEG were performed up to 24 h
after patients were at least at 35 C, and (in the vast
majority) after sedation weaning. Background reactivity
was tested on site, using auditory and painful stimulations,
at least 6 h after CA. EEG reactivity is defined as the
presence of any clear and reproducible change in amplitude
or frequency upon stimulation in the background, exclud-
ing stimulus-induced rhythmic, periodic or irritative
discharges and muscle artifacts (SIRPIDs). A discontinu-
ous pattern was defined as an EEG background interrupted
by flat periods during >10 % of the recording [15]. Epi-
leptiform activity was defined as any periodic or rhythmic
spikes or waves, as well as recurrent sharp or spikes-waves.
Statistical Analysis
The cohort was analyzed according to the outcome
(awakening versus death at 3 months; no patient remained
in vegetative state). Fischer, Student t and v2 tests were
used as needed. For statistical significant parameters, a
stepwise multivariate logistic regression analysis was per-
formed, and assessed using goodness-of fit (Hosmer–
Lemeshow). Significance was set at p < 0.05. Calcula-
tions were performed with a Stata software, version 9
(College Station, TX).
Results
During the study period, 290 patients were treated with TH
after CA; 146 had an EEG during TH (61 overlap with our
previous study [11]). In 90 (62 %) of them (38 overlapping
with [11]), this was reactive to stimulations: 77/90 (86 %)
awoke (CPC: 1–3) and 13/90 (14 %) died (none recovered
beyond a vegetative state).
Table 1 illustrates pertinent clinical and laboratory
findings according to outcome (during TH and normo-
thermia). While demographics, variables related to the CA
and serum procalcitonin were not statistically different, the
occurrence of a discontinuous EEG differed clearly
between patients who awoke and those who died. NSE
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serum peak values during TH were measured in 82 patients
(71/77 (87 %) survivors; 11/13 (13 %) non-survivors) and
were notably higher in the non-survivors group. These two
items were entered in the logistic regression using survival
as dependent variable; both remained significant (discon-
tinuous EEG: p = 0.026, OR 5.2, 95 % CI = 1.22–25.0;
NSE: p = 0.014, OR 1.05, 95 % CI = 1.01–1.10)
(Table 2). After return to normothermia, surviving patients
versus deceased patients showed full return of brainstem
reflexes (92 vs. 77 %) and motor response to pain (87 vs.
38 %); myoclonus was seen in 5 versus 23 %.
After return to normothermia, more deceased patients
developed an epileptiform EEG, a discontinuous EEG, and
lost EEG background reactivity.
Conclusions
Our study, which to the best of our knowledge represents
the first attempt to address the issue of patients having a
poor outcome despite an encouraging first EEG evaluation,
shows that non-survivors with reactive EEG have greater
extent of cerebral damage (higher NSE), but similar degree
of systemic injury (PCT levels) as compared to survivors
with reactive EEG.
Permanent neuronal damage following acute injury is
either due to rapidly occurring necrosis, or to delayed
apoptosis; it is generally assumed that necrosis and apop-
tosis are a part of a continuum of cell death [16]. Related to
our findings, the apoptotic phenomenon can possibly
underlie a somewhat delayed poor prognosis despite an
initially encouraging (reactive) EEG. Serum procalcitonin
in the acute postanoxic period is associated with the sys-
temic post-resuscitation syndrome, independently of
infections [12, 13]. This syndrome is related to a systemic
inflammation, and seems not directly associated with
neuronal damage [13]. Our results support these findings,
and suggest that the post-resuscitation syndrome is not
primarily implicated in the poor clinical evolution in
patients with initially relatively preserved EEG.
EEG discontinuity correlates with cerebral damage after
CA, but less importantly than the absence of background
reactivity [11]. In our study, after return to normothermia,
the EEG remained reactive though discontinuous in most
of the deceased patients, while about one-third developed
epileptiform transients. Even if mild hypothermia and
sedation may exert an antiepileptic action [11, 17], this
could in also part reflect the delayed apoptotic process.
NSE serum peak values during TH were significantly
higher in the non-survivors; both groups median NSE
values were beneath the cut-off of 33 lg/l. Nevertheless,
several investigators pointed out that a reliable NSE cut-off
after TH would be much higher (about 70–80 lg/l); in our
cohort, no surviving patient and 1 deceased subject showed
NSE >75 lg/l [18, 19].
Table 1 Clinical and
laboratory of 90 patients with
reactive EEG during therapeutic
hypothermia, stratified for their
outcome
Italic values indicate statistical
significance (p < 0.05)
SD standard deviation, ROSC
return of spontaneous
circulation, EEG
electroencephalography, NSE
neuron-specific enolase, PCT
procalcitonin
Survivors
n = 77
Non-survivors
n = 13
p value Test
Female gender 21 (27 %) 2 (15 %) 0.502 Fischer
Age mean (±SD) 62.2 (11.4) 60.1 (17.2) 0.564 t test
Time to ROSC median (range) 150 (5–45) 250 (5–180) 0.312 U test
Pulseless electrical activity or asystole 23 (30 %) 2 (15 %) 0.503 Fischer
Discontinuous EEG (hypothermia) 17 (22 %) 8 (62 %) 0.006 Fischer
Epileptiform EEG (hypothermia) 0 1 (7 %) 0.144 Fischer
NSE median (range) 16.9 lg/l
(6.7–70.4)
n = 71
28 lg/l
(12.2–84.7)
n = 11
0.021 U test
PCT median (range) 0.5 lg/l 2.02 lg/l 0.243 U test
(0.05–35.23) (0.06–6.7)
n = 69 n = 11
Non-reactive EEG (normothermia) 0 2 (26 %) 0.019 Fischer
Discontinuous EEG (normothermia) 11 (14 %) 9 (69 %) <0.001 Fischer
Epileptiform EEG (normothermia) 2 (3 %) 5 (38 %) 0.008 Fischer
Table 2 Multivariate analysis
Non-survivors Odds
ratio
Confidential
interval
p value
Discontinuous EEG
(hypothermia)
5.2 1.22–25 0.026
NSE 1.05 1.01–1.10 0.014
Bold values indicate statistical significance (p < 0.05)
EEG electroencephalography, NSE neuron-specific enolase
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This explorative, observational study has some limita-
tions: first, despite being the first attempt to address this
specific clinical problem, the number of patients is rela-
tively small. This explains why the groups were separated
according to survivorship (a very solid outcome) with no
further subdivisions according to the functional status.
Second, it is a single-center study, but this may enhance the
internal validity. Third, our approach does not identify cut-
off values for the serum NSE. Midazolam given during TH
may impact on the EEG background reactivity, and given
its prolonged half life may still be present in the blood of
several patients after TH; however, this did not seem
prominent in a previous study by our group [17].
A prolongation of the TH duration may be taken into
consideration in the subgroup of patients with early reac-
tive but discontinuous EEG and high serum NSE during
TH. Indeed, prolonged TH (72 h) improves the neurolog-
ical outcome in newborns after neonatal anoxia [20] but it
has not yet been investigated in adults. Furthermore, timely
availability of NSE results would be critical in this context.
Before this, our observations should be independently
confirmed in larger cohorts.
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